LeadIQ logo
Learn more at LeadIQ.com

Insights

Cutting-edge Therapeutic Development Peel Therapeutics specializes in developing innovative medicines derived from natural sources for cancer and inflammatory diseases, presenting a unique selling point for targeted therapy solutions.

Solid Financial Backing With recent seed financing totaling $36M and additional non-dilutive capital, Peel Therapeutics demonstrates financial stability and growth potential, making them an attractive partner for collaboration or investment.

Diverse Clinical Pipeline Peel Therapeutics boasts a clinical stage therapeutic pipeline that addresses a range of debilitating conditions, particularly focusing on cancer and inflammation, offering a wide array of collaboration opportunities for pharmaceutical partnerships.

Tech-Infused Drug Development Utilizing a cutting-edge tech stack including React, Google Cloud, and BugHerd, Peel Therapeutics leverages state-of-the-art technology in drug development, showcasing technological prowess that can resonate with tech-savvy clients seeking innovative solutions.

Targeted Treatment Solutions Peel Therapeutics' Neutrophil Targeting Peptides, aimed at blocking inflammation leading to immunothrombosis and fibrosis, present a promising treatment avenue, providing a compelling conversation starter for discussions with healthcare providers and researchers.

Similar companies to Peel Therapeutics

Peel Therapeutics Tech Stack

Peel Therapeutics uses 8 technology products and services including Google Analytics, cdnjs, Google Cloud, and more. Explore Peel Therapeutics's tech stack below.

  • Google Analytics
    Analytics
  • cdnjs
    Content Delivery Network
  • Google Cloud
    Infrastructure As A Service
  • BugHerd
    Issue Trackers
  • React
    Javascript Frameworks
  • RequireJS
    Javascript Frameworks
  • jQuery Migrate
    Javascript Libraries
  • Slick
    Javascript Libraries

Peel Therapeutics's Email Address Formats

Peel Therapeutics uses at least 1 format(s):
Peel Therapeutics Email FormatsExamplePercentage
FLast@peeltx.comJDoe@peeltx.com
50%
FLast@peeltx.comJDoe@peeltx.com
50%

Frequently Asked Questions

Where is Peel Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Peel Therapeutics's main headquarters is located at 630 South Komas Drive, Suite 300 Salt Lake City, Utah 84108 US. The company has employees across 2 continents, including North AmericaAsia.

What is Peel Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Peel Therapeutics's official website is peeltx.com and has social profiles on LinkedIn.

How much revenue does Peel Therapeutics generate?

Minus sign iconPlus sign icon
As of August 2024, Peel Therapeutics's annual revenue reached $1.8M.

What is Peel Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Peel Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Peel Therapeutics have currently?

Minus sign iconPlus sign icon
As of August 2024, Peel Therapeutics has approximately 17 employees across 2 continents, including North AmericaAsia. Key team members include Vice President Operations: T. F.Ceo And Co-Founder: J. S.Svp, Development Operations: D. V.. Explore Peel Therapeutics's employee directory with LeadIQ.

What industry does Peel Therapeutics belong to?

Minus sign iconPlus sign icon
Peel Therapeutics operates in the Biotechnology Research industry.

What technology does Peel Therapeutics use?

Minus sign iconPlus sign icon
Peel Therapeutics's tech stack includes Google AnalyticscdnjsGoogle CloudBugHerdReactRequireJSjQuery MigrateSlick.

What is Peel Therapeutics's email format?

Minus sign iconPlus sign icon
Peel Therapeutics's email format typically follows the pattern of . Find more Peel Therapeutics email formats with LeadIQ.
Peel Therapeutics

Peel Therapeutics

Biotechnology ResearchUtah, United States11-50 Employees

Over the course of millions of years, nature evolved to create the world’s most awe-inspiring, life-changing health outcomes. Peel Therapeutics translates these evolutionary outliers to develop medicines for patients with cancer and inflammatory diseases. 

Using scientific and medical expertise, state-of-the-art technology and drug development knowledge, we redesign what nature offers into medicines for patients by tackling solubility, scalability, and bioavailability.

Our clinical stage therapeutic pipeline treats a spectrum of devastating conditions, with a near-term focus on cancer and inflammation.

 At Peel Therapeutics, we push the limits of biology to develop highly effective and safe medicines for patients that transcend the incremental.  

Section iconCompany Overview

Headquarters
630 South Komas Drive, Suite 300 Salt Lake City, Utah 84108 US
Website
peeltx.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • $10M

    Peel Therapeutics's revenue is in the range of $10M

Section iconFunding & Financials

  • $10M

    Peel Therapeutics's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.